These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37561711)

  • 1. Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer's disease: An exploratory study.
    Yoon JA; Kong IJ; Choi I; Cha J; Baek JY; Choi J; Shin YB; Shin MJ; Lee YM
    PLoS One; 2023; 18(8):e0285013. PubMed ID: 37561711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Mild Cognitive Impairment Using Cognitive Tasks: A Functional Near-Infrared Spectroscopy Study.
    Yoo SH; Woo SW; Shin MJ; Yoon JA; Shin YI; Hong KS
    Curr Alzheimer Res; 2020; 17(13):1145-1160. PubMed ID: 33583382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
    Zhang M; Qu Y; Li Q; Gu C; Zhang L; Chen H; Ding M; Zhang T; Zhen R; An H
    J Alzheimers Dis; 2024; 98(4):1287-1300. PubMed ID: 38517784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural Compensatory Response During Complex Cognitive Function Tasks in Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study.
    Yoon JA; Kong IJ; Choi J; Baek JY; Kim EJ; Shin YI; Ko MH; Shin YB; Shin MJ
    Neural Plast; 2019; 2019():7845104. PubMed ID: 31320893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional near-infrared spectroscopy reveals decreased resting oxygenation levels and task-related oxygenation changes in mild cognitive impairment and dementia: A systematic review.
    Yeung MK; Chan AS
    J Psychiatr Res; 2020 May; 124():58-76. PubMed ID: 32120065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI.
    Tripathi M; Tripathi M; Parida GK; Kumar R; Dwivedi S; Nehra A; Bal C
    Neurol India; 2019; 67(5):1310-1317. PubMed ID: 31744965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
    J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Connectivity Analysis on Mild Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging using fNIRS.
    Tang TB; Chan YL
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():17-20. PubMed ID: 30440330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study.
    Ahn H; Yi D; Chu K; Joung H; Lee Y; Jung G; Sung K; Han D; Lee JH; Byun MS; Lee DY
    J Alzheimers Dis; 2022; 85(4):1689-1700. PubMed ID: 34958036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of brain functional connectivity in patients with mild cognitive impairment: A functional near-infrared spectroscopy (fNIRS) study.
    Nguyen T; Kim M; Gwak J; Lee JJ; Choi KY; Lee KH; Kim JG
    J Biophotonics; 2019 Sep; 12(9):e201800298. PubMed ID: 30963713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial.
    Kim J; Yon DK; Choi KY; Lee JJ; Kim N; Lee KH; Kim JG
    Alzheimers Res Ther; 2022 Mar; 14(1):39. PubMed ID: 35260170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. fNIRS as a biomarker for individuals with subjective memory complaints and MCI.
    Lee TL; Guo L; Chan AS
    Alzheimers Dement; 2024 Aug; 20(8):5170-5182. PubMed ID: 38837656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
    Wolk DA; Sadowsky C; Safirstein B; Rinne JO; Duara R; Perry R; Agronin M; Gamez J; Shi J; Ivanoiu A; Minthon L; Walker Z; Hasselbalch S; Holmes C; Sabbagh M; Albert M; Fleisher A; Loughlin P; Triau E; Frey K; Høgh P; Bozoki A; Bullock R; Salmon E; Farrar G; Buckley CJ; Zanette M; Sherwin PF; Cherubini A; Inglis F
    JAMA Neurol; 2018 Sep; 75(9):1114-1123. PubMed ID: 29799984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.